Pancreatic neuroendocrine tumors harbor recurrent somatic genetic alterations affecting genes in the PI3K/AKT/mTOR, p53, and DNA damage repair pathways. The gene discussed is TP53; the disease is pancreatic neuroendocrine tumor.